Rankings
▼
Calendar
NAUT Q1 2023 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
NAUT
Nautilus Biotechnology, Inc.
$339M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$1M
Operating Income
-$18M
Net Income
-$15M
EPS (Diluted)
$-0.12
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$346M
Total Liabilities
$42M
Stockholders' Equity
$304M
Cash & Equivalents
$89M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$1M
-$806,000
-45.3%
Operating Income
-$18M
-$16M
-12.7%
Net Income
-$15M
-$16M
+5.1%
← FY 2023
All Quarters
Q2 2023 →